SHAREHOLDERS' DEFICIENCY (Tables)

12 Months Ended

Dec. 31, 2021

SHAREHOLDERS' DEFICIENCY

Schedule of composition of ordinary share capital

	December 31, 2020		December 31, 2021
	Authorized	Issued and  outstanding	Authorized	Issued and  outstanding
	Number of shares
Ordinary shares of no-par value (*)	72,423,360	40,433,578	72,423,360	40,528,913

(*) Prior period results have been retroactively adjusted to reflect the 1: 0.905292 stock split effected on March 7, 2022. See also note 10, Shareholders’ Deficiency, for details.

Summary of the status of options and changes

	Year ended December 31, 2021
						Weighted
		Weighted				average
		average		Aggregate		remaining
	Number	exercise		intrinsic		contractual
Employees	of options	price		value		life (years)
Outstanding at beginning of year	4,062,408	$	3.40	$	944,820	7.78
Granted	1,321,211	$	9.81
Exercised	(4,809)	$	4.42
Forfeited and cancelled	(53,238)	$	5.16
Outstanding at end of year	5,325,572	$	4.97	$	17,854,046	7.42
Exercisable options	3,233,657	$	3.23	$	14,184,527	6.56

	Year ended December 31, 2021
						Weighted
		Weighted				average
		average		Aggregate		remaining
	Number	exercise		intrinsic		contractual
Service Providers	of options	price		value		life (years)
Outstanding at beginning of year	662,006	$	2.79	$	313,200	6.91
Granted	140,667	$	9.79
Exercised	(81,476)	$	1.10
Forfeited and cancelled	—
Outstanding at end of year	721,197	$	4.34	$	2,695,213	6.61
Exercisable options	580,745	$	3.05	$	2,649,873	5.89

Summary of the status of RSUs and changes

A summary of the status of RSUs under the Plan as of December 31, 2021 and changes during the relevant period ended on that date is presented below:

	Number of RSU
Outstanding at beginning of year	—
Granted	1,036,850
Forfeited and cancelled	(5,600)
Outstanding on December 31, 2021	1,031,250

Schedule equity-based compensation expense related

	Year ended  December 31,
	2019		2020		2021
Research and development	$	380	$	372	$	654
Marketing expenses		18		20		7
General and administrative		148		204		151
Total share-based compensation expense	$	546	$	596	$	812